PTHS stock

Pelthos Therapeutics Inc. (PTHS) financials · rev $16.8M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Pelthos Therapeutics Inc. (PTHS) rev $16.8M.

Cached annual income statement
LineFY2025FY2024
Revenue$16.8MN/A
Cost of Revenue$3.99MN/A
Gross Profit$12.8MN/A
Operating Income-$32.4M-$7.57M
Net Income-$43.3M-$7.96M
EPS (Diluted)-$23.04-$1.43
Cached annual balance sheet
LineFY2025FY2024
Total Assets$130.4M$1.37M
Current Assets$53.4M$1.37M
Cash & Equivalents$18.0M$513.0K
Inventory$23.6M$0
PP&E$9.59MN/A
Total Liabilities$91.5M$4.08M
Current Liabilities$26.0M$4.08M
Shareholders' Equity$38.9M-$2.71M
Retained Earnings-$64.8M-$21.5M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$22.6M-$5.79M
CapEx$99.0KN/A
Investing Cash Flow-$5.24MN/A
Financing Cash Flow$45.3M$6.21M
Free Cash Flow-$22.7M-$5.79M
These statements as JSON? API free 100/day

FAQ

What is PTHS P/E and revenue?

Pelthos Therapeutics Inc. (PTHS) rev $16.8M.

What is PTHS revenue?

Pelthos Therapeutics Inc. last cached revenue is $16.8M (FY2025).

Is PTHS profitable?

Pelthos Therapeutics Inc. last cached net income is -$43.3M (FY2025).

What are PTHS total assets?

Pelthos Therapeutics Inc. last cached total assets are $130.4M (FY2025).

What is PTHS free cash flow?

Pelthos Therapeutics Inc. last cached free cash flow is -$22.7M (FY2025).

Not investment advice. Cached statements, not a live tape.